3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
3
Seizures
3
Sturge-Weber Syndrome
2
Nausea
2
Vomiting
1
Parasomnias
1
Pain
1
Neoplasms
1
Marijuana Abuse
1
Dysgeusia
1
Drug Resistant Epilepsy
1
Cognitive Dysfunction
1
Chemotherapy-Induced Peripheral Neuropathy
1
Cancer Pain
1
Cachexia
1
Breast Neoplasms
1
Behavior
1
Arthralgia
1
Appetitive Behavior
1
Anxiety Disorders
1
Interventions
Counseling
3
Surveys and Questionnaires
2
Motivational Interviewing
2
College Fraternities and Sororities
2
Transportation
1
Spermine Synthase
1
Risk Factors
1
Risk Assessment
1
Riluzole
1
Price Transparency
1
Palliative Care
1
Interviews as Topic
1
House Calls
1
Ethanol
1
Educational Status
1
Decision Support Techniques
1
Cannabidiol
1
Acceptance and Commitment Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Behavior
×
Cannabidiol
×
Clear all
NCT05864846
2026-04-27
EpiCom
Jazz Pharmaceuticals
Phase 4
Completed
79 enrolled